Predictive Modeling of Drug Response in Non-Hodgkin’s Lymphoma
Hermann B. Frieboes(University of Louisville), Vittorio Cristini(Houston Methodist)
Cited by 25
Related Papers
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial
|The Lancet. Gastroenterology & hepatology|2022|255
A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma
|Clinical Cancer Research|2018|111
An Integrated Computational/Experimental Model of Lymphoma Growth
|PLoS Computational Biology|2013|35
Modeling of Nanotherapy Response as a Function of the Tumor Microenvironment: Focus on Liver Metastasis
|Frontiers in Bioengineering and Biotechnology|2020|13